Results should be in the media somewhere but, what is important to PIQ is that PIQ is earning revenue from these trials of the Biosimilars that it has developed. The list of successfully developed Biosimilars by PIQ is growing. The revenue from the Lab. is about $2.7m, I think, and growing.
Potential revenue from PromarkerD: US $18m p.a for Spain alone.
Ann: PromarkerD latest results published in peer reviewed journal, page-26
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.5¢ |
Change
-0.005(0.59%) |
Mkt cap ! $110.6M | |||
| Open | High | Low | Value | Volume |
| 85.0¢ | 89.5¢ | 83.0¢ | $206.2K | 238.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | 83.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 764 | 1 |
View Market Depth
| Last trade - 15.57pm 16/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |